Company News

P&G’s Teva Deal Gets OK from EU

PGT Healthcare will have $1.3 billion in sales.

Author Image

By: TOM BRANNA

Editor

P&G has a partner in the OTC drug business. European regulators cleared Procter & Gamble and Teva Pharmaceuticals to form a joint venture to sell over-the-counter medicines such as Vicks, Metamucil and Pepto-Bismol. The new JV, PGT Healthcare, will have sales of $1.3 billion and will include Teva’s lines of over-the-counter cold and other medicines, as well as its pharmacy distribution network. The firms think the joint venture could grow sales to about $4 billion a year b...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters